Literature DB >> 8995646

Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy.

W Zou1, A A Lackner, M Simon, I Durand-Gasselin, P Galanaud, R C Desrosiers, D Emilie.   

Abstract

Competitive PCR was used to evaluate the expression of cytokine, granzyme B, and chemokine genes in lymph nodes of macaques recently infected with the simian immunodeficiency virus (SIV) pathogenic molecular clone SIVmac239 (n = 16), the nonpathogenic vaccine strain SIVmac239 delta nef (n = 8), and the nonpathogenic molecular clone SIVmac1A11 (n = 8). For both SIVmac239 and its nef-deleted derivative, strong expression was observed as early as 7 days postinfection for interleukin 1beta (IL-1beta), IL-6, tumor necrosis factor alpha, gamma interferon, and IL-13. The levels of gene induction were equally intense for both viruses despite a lower viral load for SIVmac239 deltanef compared with that for SIVmac239. However, the nature of the cytokine network activation varied with the viral inocula. Primary infection with SIVmac239 was characterized by a higher level of IL-4, IL-10, MIP-1alpha, MIP-1beta, MCP-1, and RANTES gene expression and a lower level of IL-12 and granzyme B gene expression compared with infection with SIVmac239 delta nef. Thus, infection with nef-deleted SIV was associated with a preferential Th1 versus Th2 pattern of cytokine production. Infection with SIVmac1A11 was characterized by a delayed immune response for all markers tested. The unique patterns of cytokine and chemokine gene expression in lymph nodes correlated nicely with the pathogenic potential of the SIV strains used as well as with differences in their ability to serve as protective vaccines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995646      PMCID: PMC191177     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques.

Authors:  M von Herrath; M B Oldstone; H S Fox
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

2.  Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys.

Authors:  Z Du; S M Lang; V G Sasseville; A A Lackner; P O Ilyinskii; M D Daniel; J U Jung; R C Desrosiers
Journal:  Cell       Date:  1995-08-25       Impact factor: 41.582

3.  Vaccine protection against simian immunodeficiency virus infection.

Authors:  R C Desrosiers; M S Wyand; T Kodama; D J Ringler; L O Arthur; P K Sehgal; N L Letvin; N W King; M D Daniel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

Review 4.  Role of TH1/TH2 cytokines in HIV infection.

Authors:  S Romagnani; G Del Prete; R Manetti; A Ravina; F Annunziato; M De Carli; M Mazzetti; M P Piccinni; M M D'Elios; P Parronchi
Journal:  Immunol Rev       Date:  1994-08       Impact factor: 12.988

5.  Priming for high interferon-gamma production induced by interleukin-12 in both CD4+ and CD8+ T cell clones from HIV-infected patients.

Authors:  C Paganin; I Frank; G Trinchieri
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

6.  Progression to AIDS in the absence of a gene for vpr or vpx.

Authors:  J S Gibbs; A A Lackner; S M Lang; M A Simon; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

7.  HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization.

Authors:  A S Baur; E T Sawai; P Dazin; W J Fantl; C Cheng-Mayer; B M Peterlin
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

8.  In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation.

Authors:  S W Chensue; J H Ruth; K Warmington; P Lincoln; S L Kunkel
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

9.  Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus.

Authors:  M O Smith; M P Heyes; A A Lackner
Journal:  Lab Invest       Date:  1995-05       Impact factor: 5.662

10.  T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus.

Authors:  Z W Chen; Z C Kou; C Lekutis; L Shen; D Zhou; M Halloran; J Li; J Sodroski; D Lee-Parritz; N L Letvin
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

View more
  29 in total

1.  Influence of supramammary lymph node extract on in vitro cell proliferation.

Authors:  D M Duffy; S M Garrett; S E Ellis; T R Scott
Journal:  Cell Prolif       Date:  2008-04       Impact factor: 6.831

2.  Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice.

Authors:  U F Power; T Huss; V Michaud; H Plotnicky-Gilquin; J Y Bonnefoy; T N Nguyen
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus.

Authors:  L D Giavedoni; M C Velasquillo; L M Parodi; G B Hubbard; V L Hodara
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection.

Authors:  Philip J Norris; Brandee L Pappalardo; Brian Custer; Gerald Spotts; Frederick M Hecht; Michael P Busch
Journal:  AIDS Res Hum Retroviruses       Date:  2006-08       Impact factor: 2.205

Review 5.  Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development.

Authors:  Sheila M Keating; Evan S Jacobs; Philip J Norris
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

6.  The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection.

Authors:  J D Lifson; M A Nowak; S Goldstein; J L Rossio; A Kinter; G Vasquez; T A Wiltrout; C Brown; D Schneider; L Wahl; A L Lloyd; J Williams; W R Elkins; A S Fauci; V M Hirsch
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques.

Authors:  A A Ansari; A E Mayne; J B Sundstrom; P Bostik; B Grimm; J D Altman; F Villinger
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

8.  Simian immunodeficiency virus infects follicular helper CD4 T cells in lymphoid tissues during pathogenic infection of pigtail macaques.

Authors:  Yin Xu; Chris Weatherall; Michelle Bailey; Sheilajen Alcantara; Robert De Rose; Jerome Estaquier; Kim Wilson; Kazuo Suzuki; Jacques Corbeil; David A Cooper; Stephen J Kent; Anthony D Kelleher; John Zaunders
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

9.  Lower levels of gamma interferon expressed by a pseudotyped single-cycle simian immunodeficiency virus enhance immunogenicity in rats.

Authors:  Yue Peng; Fan-ching Lin; Paulo H Verardi; Leslie A Jones; Tilahun D Yilma
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

10.  Increased expression of monocyte CD44v6 correlates with the deveopment of encephalitis in rhesus macaques infected with simian immunodeficiency virus.

Authors:  Maria Cecilia G Marcondes; Caroline M S Lanigan; Tricia H Burdo; Debbie D Watry; Howard S Fox
Journal:  J Infect Dis       Date:  2008-06-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.